Effects of soluble guanylate cyclase activator vericiguat on fracture healing in rats
Joint Diseases and Related Surgery · 01.04.2026 · 37 (2) · 519-530
DOI: 10.52312/jdrs.2026.2655 ↗Kurz gefasst
Fachartikel in der Zeitschrift Joint Diseases and Related Surgery, online erschienen am 16.03.2026. Verfasst von Azat Dzhumukov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Atatürk Üniversitesi Hastanesi, Ortopedi ve Travmatoloji Kliniği, 25040 Yakutiye, Erzurum, Türkiye. azat.dzhumukov@gmail.com. Hauptthemen laut MEDLINE: Fracture Healing, Femoral Fractures, Soluble Guanylyl Cyclase, Enzyme Activators. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Atatürk Üniversitesi Hastanesi, Ortopedi ve Travmatoloji Kliniği, 25040 Yakutiye, Erzurum, Türkiye. azat.dzhumukov@gmail.com.
Zitieren
APA
Dzhumukov, A., Karabak, B., Demirci, A., Hoyur, F. Y., & Engin, M. Ç. (2026). Effects of soluble guanylate cyclase activator vericiguat on fracture healing in rats. Joint Diseases and Related Surgery, 37(2), 519-530. https://doi.org/10.52312/jdrs.2026.2655
Vancouver
Dzhumukov A, Karabak B, Demirci A, Hoyur FY, Engin MÇ. Effects of soluble guanylate cyclase activator vericiguat on fracture healing in rats. Joint Diseases and Related Surgery. 2026;37(2):519-530. doi:10.52312/jdrs.2026.2655
BibTeX
@article{Dzhumukov2026,
author = {Dzhumukov, Azat and Karabak, Bilal and Demirci, Aziz and Hoyur, Ferhat Yıldırım and Engin, Muhammed Çağatay},
title = {Effects of soluble guanylate cyclase activator vericiguat on fracture healing in rats},
journal = {Joint Diseases and Related Surgery},
year = {2026},
volume = {37},
number = {2},
pages = {519--530},
doi = {10.52312/jdrs.2026.2655}
}
EUVIMED